OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Pharmacokinetics is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor	85
Pharmacokinetics and Drug–Drug Interactions of Long-Acting Intramuscular Cabotegravir and Rilpivirine	59
Etomidate and its Analogs: A Review of Pharmacokinetics and Pharmacodynamics	56
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials	49
Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes	46
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs	44
DeepIDC: A Prediction Framework of Injectable Drug Combination Based on Heterogeneous Information and Deep Learning	42
Contribution of the Gut Microbiome to Drug Disposition, Pharmacokinetic and Pharmacodynamic Variability	41
Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology	40
Effects of Renal Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide	33
Clinical Pharmacokinetics and Pharmacodynamics of Cefepime	33
Therapeutic Drug Monitoring in Non-Tuberculosis Mycobacteria Infections	32
Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update	30
Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics	30
Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma	28
Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review	28
A Review of Population Pharmacokinetic Analyses of Linezolid	28
Population Pharmacokinetics of Levetiracetam: A Systematic Review	27
Pharmacokinetic Alterations Associated with Critical Illness	27
Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction	26
Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin	25
Clinical Pharmacokinetics of Daptomycin	25
Population Pharmacokinetics of a Monthly Buprenorphine Depot Injection for the Treatment of Opioid Use Disorder: A Combined Analysis of Phase II and Phase III Trials	24
Clinical Pharmacokinetics and Pharmacodynamics of Selumetinib	24